|
Access to and type of credit
|
Stock
|
Odds ratios
|
|---|
|
Yes n (%)
|
No n (%)
|
Crude odds ratio (95% CI)
|
Adjusted odds ratioa (95% CI)
|
|---|
|
Oral Rehydration Salts (ORS)
|
|
No Financial Loan
|
43(69)
|
19(31)
|
1
|
1
|
|
Financial Loan
|
40(67)
|
20(33)
|
1.03(.53–1.99)
|
1.12(0.56–2.23)
|
|
No Stock Credit
|
112(64)
|
64(36)
|
1
|
1
|
|
Stock Credit
|
60(74)
|
21(26)
|
1.07(0.65–1.720)
|
1.22(0.60–2.50)
|
|
Zinc dispersible Tablets
|
|
No Financial Loan
|
41(66)
|
21(34)
|
1
|
1
|
|
Financial Loan
|
30(50)
|
30(50)
|
0.766(.40–1.43)
|
0.90(0.46–1.78)
|
|
No Stock Credit
|
104(59)
|
72(41)
|
1
|
1
|
|
Stock Credit
|
49(60)
|
32(40)
|
0.95(0.60–1.50)
|
1(0.50–2.0)
|
|
Artemether Lumefantrine combined oral treatments
|
|
No Financial Loan
|
53(84)
|
9(16)
|
1
|
1
|
|
Financial Loan
|
42(70)
|
18(30)
|
0.46(.20–1.03)
|
0.45(0.18–1.1)
|
|
No Stock Credit
|
128(73)
|
48(27)
|
1
|
1
|
|
Stock Credit
|
60(74)
|
21(26)
|
1.19(0.70–2.00)
|
1.9(0.77–4.8)
|
|
Amoxicillin Dispersible tabs
|
|
No Financial Loan
|
9(16)
|
53(84)
|
1
|
1
|
|
Financial Loan
|
9(15)
|
53(85)
|
1.14(0.5–2.52)
|
1.24(0.52–3.0)
|
|
No Stock Credit
|
27(15)
|
149(85)
|
1
|
1
|
|
Stock Credit
|
14(17)
|
67(83)
|
1.28(0.72–2.27)
|
1.16(0.50–2.7)
|
|
Amoxicillin 125 mg syrups
|
|
No Financial Loan
|
50(81)
|
12(19)
|
1
|
1
|
|
Financial Loan
|
28(47)
|
32(53)
|
0.47(.24–0 .89)
|
0.43(0.23–0.9)
|
|
No Stock Credit
|
105(60)
|
71(40)
|
1
|
1
|
|
Stock Credit
|
54(67)
|
27(33)
|
1.16(0.73–1.84)
|
1(0.54–2.2)
|
-
aAdjusted for residence, outlet type and licensing status
